Peter Bernhardt

Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients

Howard J. Eisen, E. Murat Tuzcu, Richard Dorent et al. · New England Journal of Medicine · 2003 · 1.2K citations · Full text

Medicine, Immunology, Transplant Surgery +4

Everolimus with Optimized Cyclosporine Dosing in Renal Transplant Recipients: 6-Month Safety and Efficacy Results of Two Randomized Studies

Hélio Tedesco‐Silva, Josette Eris, Julio Pascual et al. · American Journal of Transplantation · 2004 · 257 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation

Julio Pascual, Stefan P. Berger, Oliver Witzke et al. · Journal of the American Society of Nephrology · 2018 · 244 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study

Stefan P. Berger, Claudia Sommerer, Oliver Witzke et al. · American Journal of Transplantation · 2019 · 149 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +17

Efficacy and safety of enteric-coated mycophenolate sodium in combination with two glucocorticoid regimens for the treatment of active lupus nephritis

Margit Zeher, Andrea Doria, Jong-Liang Lan et al. · Lupus · 2011 · 147 citations

Medicine, Pharmacology, Pharmacotherapy +15